Researchers, physician-scientists, trainees, and community members across Columbia gathered to explore the rapidly evolving field of cancer metabolism.
After participating in HICCC's Community Science Institute, Monifa Maat joined Columbia full-time, continuing her work blending arts and research to combat health disparities in her community.
Joel DeCastro, MD, MPH, debunks some of the most common myths surrounding prostate cancer, like outdated beliefs about screening tests, treatment options, and its effect on sexual health.
Adana Llanos, PhD, MPH, discusses the latest in breast cancer inequities following the American Cancer Society (ACS) biennial update of breast cancer statistics among women in the United States.
Columbia researchers led by Nicholas Arpaia, PhD, and Tal Danino, PhD, have engineered probiotic bacteria that educate the immune system to destroy cancer cells.
Arith Reyes, MD, shares the latest research on breast cancer patients who opted for breast-conservation surgery, such as lumpectomy, and those who underwent mastectomies.
A new paper from Elham Azizi's lab and collaborators has been accepted in Genome Research, marking a significant advancement in the study of dynamic single-cell interactions.
Ricardo Cruz-Acuña, PhD' s hunger for research and learning began early. Now, with his own lab at the HICCC, he advocates for the new generation of underrepresented minority scientists.
The Gaublomme lab has developed a new optical pooled screening approach called CRISPRmap, which enables the coupling of optical properties of single cells to targeted genetic perturbations.